Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Gold Fields Limited (GFI) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gold Fields Limited (GFI) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for April 27th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 27th:
Avenue Therapeutics, Inc. (ATXI - Free Report) : This specialty pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.6% over the last 60 days.
Avenue Therapeutics, Inc. Price and Consensus
Avenue Therapeutics, Inc. price-consensus-chart | Avenue Therapeutics, Inc. Quote
Avenue Therapeutics’ shares gained 15.4% over the last one month above the S&P 500’s increase of 7.9%. The company possesses a Momentum Score of A.
Avenue Therapeutics, Inc. Price
Avenue Therapeutics, Inc. price | Avenue Therapeutics, Inc. Quote
Can-Fite BioPharma Ltd. (CANF - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.9% over the last 60 days.
Can-Fite Biopharma Ltd Price and Consensus
Can-Fite Biopharma Ltd price-consensus-chart | Can-Fite Biopharma Ltd Quote
Can-Fite BioPharma’s shares gained 25.9% over the last one month. The company possesses a Momentum Score of A.
Can-Fite Biopharma Ltd Price
Can-Fite Biopharma Ltd price | Can-Fite Biopharma Ltd Quote
Gold Fields Limited (GFI - Free Report) : This gold producer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 45% over the last 60 days.
Gold Fields Limited Price and Consensus
Gold Fields Limited price-consensus-chart | Gold Fields Limited Quote
Gold Fields’ shares gained 41.5% over the last one month. The company possesses a Momentum Score of B.
Gold Fields Limited Price
Gold Fields Limited price | Gold Fields Limited Quote
Manning & Napier, Inc. : This investment manager has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.2% over the last 60 days.
Manning & Napier, Inc. Price and Consensus
Manning & Napier, Inc. price-consensus-chart | Manning & Napier, Inc. Quote
Manning & Napier’s shares gained 159.8% over the last one month. The company possesses a Momentum Score of B.
Manning & Napier, Inc. Price
Manning & Napier, Inc. price | Manning & Napier, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>